• Ownership

Jeffrey V. Poulton - Insider Trading & Ownership

Entity
Individual
Location
300 Third Street, Cambridge, MA
Summary
The estimated net worth of Jeffrey V. Poulton is at least $12.6M dollars as of March 5, 2025. Jeffrey V. Poulton is the EVP, Chief Financial Officer of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $12.3M. Jeffrey V. Poulton is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $309K.
All Insider Reports
All Insider Reports

Ownership of Jeffrey V. Poulton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer $12.3M -$1.54M -11.1% Mar 3, 2025
QTTB Q32 Bio Inc. Director $309K Jun 14, 2023
CRVO CervoMed Inc. Director Jun 14, 2024

Insider Transactions Reported by Jeffrey V. Poulton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.